New drug treatments for epilepsy

Journal of Neurology Neurosurgery and Psychiatry

Volumn 70, Issue 2, 2001, Pages 143-147

  Marson, A G ^a   Chadwick, D W ^a  

^a Clinical Sciences Centre for Research and Education   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; NEW DRUG; OXCARBAZEPINE; PHENYTOIN; REMACEMIDE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EPILEPSY; HUMAN; LENNOX GASTAUT SYNDROME; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

ANTICONVULSANTS; EPILEPSY; HUMANS;

EID: 0035146102     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.70.2.143     Document Type: Review

References (42)

1. New antiepileptic drugs: A systematic review of their efficacy and tolerability
2. The new antiepileptic drugs: A systematic review of their efficacy and tolerability
3. Efficacy and safety of topiramate in generalized tonic-clonic seizures of non-focal origin
4. Gabapentin in generalized seizures
5. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome
6. Topiramate as adjunctive therapy in lennox-gastaut syndrome
7. Quality of life in people with epilepsy: A European study
8. Open randomized comparative study of vigabatrin (VGB) and lamotrigine (LTG) efficacy in monotherapy of patients with drug-resistant epilepsy with partial complex seizures resistent to carbamazepine (CBZ)
9. New antiepileptic drugs. Analysis based on number needed to treat shows differences between drugs studied
10. Polypharmacy with anticonvulsants: Focus on synergism
11. Long term use of lamotrigine and vigabatrin in severe refractory epilepsy: Audit of outcome
12. Topiramate in clinical practice: First years experience in a specialist epilepsy clinic
13. Vigabatrin withdrawal randomized study in children
14. Efficacy and tolerability of vigabatrin in children with refractory partial seizures: A single-blind dose-increasing study
15. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: A randomized, double-blind, crossover study
16. Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis
17. Severe persistent visual field constriction associated with vigabatrin
18. Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study
19. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects
20. Commission on Antiepileptic Drugs. Guidelines for the clinical evaluation of antiepileptic drugs
21. Trials to assess equivalence: The importance of rigorous methods
22. Considerations on designing clinical trials to evaluate the place of new antiepileptic drugs in the treatment of newly diagnosed and chronic patients with epilepsy
23. Hazards of inference: The active control investigation
24. Topiramate monotherapy for partial onset seizures
25. Oxcarbazepine: Double-blind, randomized, placebo-control, monotherapy trial for partial seizures
26. Felbamate: A double blind controlled trial in patients undergoing presurgical evaluation of partial seizures
27. Gabapentin monotherapy I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures
28. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
29. A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy
30. A multicenter double blind randomized comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy
31. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures
32. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: A multicentre randomised double-blind study
33. Vigabatrin vs carbamazepine monotherapy in newly diagnosed focal epileptics: A randomized response conditional crossover study
34. A double blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy
35. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy
36. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy
37. A double-blind controlled clinical trial: Oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy
38. Systematic reviews and their relevance to epilepsy